Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | P2RX7 | Q99572 | 6/20 | 0.34 |
| ▸ | TRPA1 | O75762 | 2/20 | 0.33 |
| ▸ | TRPV1 | Q8NER1 | 2/20 | 0.33 |
| ▸ | DHODH | Q02127 | 1/20 | 0.32 |
| ▸ | SLC16A3 | O15427 | 4/20 | 0.31 |
| ▸ | SLC16A1 | P53985 | 4/20 | 0.31 |
| ▸ | RORC | P51449 | 1/20 | 0.31 |
| ▸ | MCTS1 | Q9ULC4 | 2/20 | 0.31 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.30 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.30 |
| ▸ | MEN1 | O00255 | 1/20 | 0.30 |
| ▸ | PPARG | P37231 | 1/20 | 0.30 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.30 |
| ▸ | NR2E3 | Q9Y5X4 | 1/20 | 0.30 |
| ▸ | NCOR2 | Q9Y618 | 1/20 | 0.30 |
| ▸ | MALT1 | Q9UDY8 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29454971 | 1.00 | P2RX7 (0.34) | P2RX7TRPA1TRPV1DHODHSLC16A3 | |
| SCHEMBL23142280 | 0.92 | MARS1 (0.35) | P2RX7TRPA1TRPV1DHODHSLC16A3 | |
| SCHEMBL30388796 | 0.91 | P2RX7 (0.33) | P2RX7TRPA1TRPV1DHODHSLC16A3 | |
| SCHEMBL15862865 | 0.89 | DHODH (0.36) | TRPA1TRPV1DHODHSLC16A3SLC16A1 | |
| SCHEMBL23142315 | 0.84 | P2RX7 (0.36) | P2RX7KDM4EL3MBTL1MEN1KMT2A | |
| SCHEMBL24287198 | 0.82 | TRPA1 (0.34) | TRPA1TRPV1DHODHSLC16A3SLC16A1 | |
| SCHEMBL385572 | 0.82 | KDM4E (0.44) | TRPA1TRPV1SLC16A3SLC16A1KDM4E | |
| SCHEMBL12112877 | 0.81 | KDM4E (0.34) | P2RX7TRPA1TRPV1DHODHSLC16A3 | |
| SCHEMBL13085032 | 0.81 | NTRK1 (0.34) | TRPV1DHODHMALT1 | |
| SCHEMBL684736 | 0.80 | NTRK1 (0.33) | TRPV1DHODHMALT1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12545661-B2 | Process for preparing a tetrazole-substituted anthranilic acid diamide derivative | BAYER AKTIENGESELLSCHAFT (DE) | 2026-02-10 | — | — | US | disclosed |
| US-20230339899-A1 | PROCESS FOR PREPARING A TETRAZOLE-SUBSTITUTED ANTHRANILIC ACID DIAMIDE DERIVATIVE | BAYER AKTIENGESELLSCHAFT (DE) | 2023-10-26 | — | — | US | disclosed |
| CN-116057054-A | Process for preparing tetrazole-substituted anthranilic acid diamide derivatives | 拜耳公司 | 2023-05-02 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230339899-A1 | PROCESS FOR PREPARING A TETRAZOLE-SUBSTITUTED ANTHRANILIC ACID DIAMIDE DERIVATIVE | ALAD, DAO, AASDHPPT | P2RX7 1801/4885TRPA1 1960/4885TRPV1 2518/4885 |
| US-12545661-B2 | Process for preparing a tetrazole-substituted anthranilic acid diamide derivative | ACMSD, ADH1C, ADH1A | P2RX7 3439/4885TRPA1 753/4885TRPV1 1216/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.